GAD1 and type 1 diabetes mellitus: Only a few studies conducted in Saudi Arabia [11], the UAE [12], Sudan [13], Iran [14], and Qatar [15] have reported GAD to be the most commonly detected autoantibody in patients with T1D in Arab countries.